Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
You would think it has been completed ! As you say the £8k was paid last year and we were expected to get the £55k+ last year , even taking covid into account that’s a long time to complete one research project .
Sphinx, the interim results showed income of £8,346 for Fruitflow+ nitrates - in development.
Doesn't indicate this is from by-health but assume it is. You are correct though we are still due the remaining cash if we have completed the work.
Gixer shouldn’t we get the ff+nitrates money from By-health (£47k) in these coming results , I also wonder if any other research projects have been commissioned from byhealth , but who knows with pxs and results .
Kievsky
You have know idea what the price maybe so why speculate
We all just have to be patient. Will explode once approved and announced. Then DSM and bi-Heath will have to fight for us. As I said I want 5p plus. 10p would be a great result. But on spike it could go to 12p plus at some time. Of course if blue hat gets refused then we will hope bi-health release there products without it.
Hi gixer,
Many thanks for your very informative post. Hope By Health will be our saviour and want to buy us outright with the right price tag. Then suddenly DSM wakes up and made a counter offer. Probably SL will have the key decision to go which direction we should go.
1 of 2
I know I have posted this before but its worth reading again.
From By-Health Institute of Nutrition and Health.
New Function Research.
With the gradual improvement of the living standards and health awareness of residents across the country, as an important part of the "Healthy China" strategy, it is imperative to carry out research on new functions of health foods.
The new function of health food is a health function that is not within the scope of the current health function published by the State Food and Drug Administration, and is fundamentally different from the name of the current health function and its functional evaluation method.
In order to better meet people's health needs, the Institute integrates the resources of authoritative nutrition and health research institutions at home and abroad, and continuously explores the innovative research field of "new functions, new materials, and new technologies", and has been in the field of new functional products for cardiovascular health. Achieved certain results.
Research Background
In 2009, EFSA approved the first health claim study on "Water-soluble tomato concentrate helps maintain normal platelet aggregation and helps healthy blood flow". This is the first product that has passed the European Food Safety Authority (EFSA) Act 13.5 on the claims of new functions, and has been approved by EFSA's first new health care function. The scientific opinion issued by the European Food Safety Agency (EFSA) in 2011 pointed out that cardiovascular health function claims include adjusting blood lipids, lowering blood pressure, maintaining normal endothelial function, and reducing platelet aggregation. In this scientific opinion, it is pointed out that "in subjects with high cardiovascular (CV) risk factors (such as smokers, hypercholesterolemia subjects, obesity, diabetes), their platelets are prone to be overactive and hypercoagulable. And it is closely related to the occurrence and development of atherosclerosis and its complications.
In the 2018 China Cardiovascular Disease Risk Assessment and Management Guidelines, increased platelet aggregation has been listed as a potential risk factor for cardiovascular disease. Therefore, the development of different interventions against platelet aggregation has now become a goal of maintaining cardiovascular health. Among them, the research on the new functions of health food in the cardiovascular field has extremely high necessity and feasibility.
Research progress
In recent years, the company has taken "Fruitflow® (water-soluble tomato concentrate)" as its main direction, focusing on the development of new functional products that help maintain cardiovascular health.
2 of 2
The project brought together domestic authoritative scientific research resources such as the Institute of Chinese Materia Medica of the Chinese Academy of Chinese Medical Sciences and the School of Public Health of Sun Yat-Sen University, and adopted By-Health ® Xinluo Su Tablets (the main functional ingredients are the same as those approved by EFSA, all are water-soluble tomato concentrates). Experimental samples, refer to domestic and foreign literature and methods approved and published by EFSA, and conducted in-depth investigations around related issues, and finally determined to establish a new function of "help maintain normal platelet aggregation and contribute to healthy blood flow". Animal function test evaluation of health food Methods and evaluation methods of the population test.
At present, this method has been repeatedly verified in Beijing Hospital, Peking University Third Hospital, Dongzhimen Hospital of Beijing University of Chinese Medicine, China Academy of Chinese Medical Sciences, Sun Yat-sen University and other domestic research institutions. The test results prove that the method has wide applicability, easy operation and detection. The results are reproducible. The project seeks safer antiplatelet substances to maintain normal platelet aggregation, reduces the risk factors for the occurrence and development of cardiovascular diseases, and makes an effective exploration for the research on new functions of health foods and the profound significance of maintaining public health.
https://www.binh.cn/aboutUs?id=713b66daab974fafab39d8b09002b2e3&title=%E5%85%B3%E4%BA%8E%E6%96%B0%E5%8A%9F%E8%83%BD%E7%A0%94%E7%A9%B6&navTitle=%E9%A6%96%E9%A1%B5%20%3E%20%E6%96%B0%E5%8A%9F%E8%83%BD%E7%A0%94%E7%A9%B6%20%3E%20%E5%85%B3%E4%BA%8E%E6%96%B0%E5%8A%9F%E8%83%BD%E7%A0%94%E7%A9%B6%20%3E%20%E8%AF%A6%E6%83%85&menuItemId=b04733902fc64eaa80a0b7e54e39a200
wellsite, I have no doubt at all that By-Health will achieve Blue Hat for Fruitflow. What might be more tricky is getting the New function claim.
ATM there are 27 function claims (soon 24) but can you imagine if one of those claims were to be related to the reduction of platelet aggregation?
https://www.cirs-reach.com/news-and-articles/New-Methods-for-Functional-Assessment-of-Health-Food-Drafts-Issued-in-China.html
"At present, the company has developed more than 30 customized raw materials and obtained more than 60 invention patents for raw materials and formulas. At the same time, the company is carrying out the research and development of new functions beyond 27 functions, and the research and development of new detection technologies, evaluation methods, health big data, functional products, knowledge maps, intelligent algorithms and other technologies related to precise nutrition. The company will integrate internal and external resources to focus on innovative research and development, and continue to create innovative products with new functions, new formulations and new technologies"
https://translate.google.com/translate?hl=en&sl=zh-CN&u=http://finance.china.com.cn/roll/20210805/5624609.shtml&prev=search&pto=aue
Nothing we can do about Holland and Barrett's performance I am afraid but if it makes you feel any better I have never seen FF+ in my local H&B store.
One day I might go in and look though :)
We may all have supply issues if By-Health launch their new product !!!! They must be very confident in getting blue hat to post it on their site
Research comprehensively in the cardiovascular health area. We have developed a new product made with Fruitflow®, popularly known as “natural Aspirin”. It helps to maintain normal platelet aggregation;
https://www.by-health.com/en/aboutus/
W$
I was commenting on company performance, rather than my personal supply issues.
But thanks anyway. lol.
Next day delivery at my HB
I haven't seen FruitFlow in my local H&B in over a year.